Differences between Ecstasy-using and nonusing methamphetamine users.
Differences between Ecstasy-using and nonusing methamphetamine users.
复制标题
使用摇头丸和不使用甲基苯丙胺使用者之间的差异。
DOI：
10.1080/02791072.2002.10399956
复制
发表时间：
2002
期刊：
影响因子：
--
通讯作者：
vonMayrhauser,Christina
中科院分区：
文献类型：
--
作者：
Brecht,Mary-Lynn;vonMayrhauser,Christina
最近摇头丸的使用量出现惊人的增长，并且越来越多的证据表明可能产生长期的神经和认知影响。本文在常见的多种药物背景下考虑摇头丸的使用（特别是甲基苯丙胺[MA]），研究使用摇头丸的患者和不使用摇头丸的患者亚组之间的差异，并探讨摇头丸的使用与选定的治疗结果的关系。多变量逻辑回归显示，摇头丸+MA使用者与未使用摇头丸的MA使用者的不同主要体现在社会人口统计学（更高的收入、更少的孩子）、药物滥用行为和动机（更多类型的药物的终生史、更有可能报告使用摇头丸来增强性能力、更多与药物相关的问题）、生活方式（更有可能有同性性伴侣）和治疗特征（入院时年龄较小、较少）。 可能完成治疗）。即使在控制其他与摇头丸相关的特征时，使用摇头丸预计治疗完成率也会较低；然而，复发时间与摇头丸的使用没有显着相关。这些区分兴奋剂使用者亚组的结果可能有助于指导对摇头丸使用的特定行为原因和相关性的进一步研究，这反过来又可以指导摇头丸使用者有前景的 MA 相关治疗方法的专业化。
There have been recent alarming increases in Ecstasy use and growing evidence of possible long-term neurological and cognitive effects. This article considers Ecstasy use within its common polydrug context (specifically with methamphetamine [MA]), examining differences between Ecstasyusing and nonusing subgroups of clients treated for MA use, and exploring the relationship of Ecstasy use to selected treatment outcomes. Multivariate logistic regression showed Ecstasy+MA users differing from MA users who have not used Ecstasy primarily in terms of sociodemographics (higher income, fewer children), substance abuse behaviors and motivators (lifetime history of more types of drugs, more likely to report use of Ecstasy to enhance sex, more drug-related problems), lifestyle (more likely to have had same-sex sex partners), and treatment characteristics (younger at admission, less likely to complete treatment). A lower rate of treatment completion was predicted by Ecstasy use, even when controlling for other Ecstasy-related characteristics; however, time to relapse was not significantly related to Ecstasy use. These results distinguishing subgroups of stimulant users may help guide additional research into specific behavioral causes and correlates of Ecstasy use, which could in turn guide specialization of promising MA-related treatment approaches for Ecstasy users.